ADVANCED CELL TECHNOLOGY, INC. 4/A
4/A · ADVANCED CELL TECHNOLOGY, INC. · Filed Sep 18, 2014
Insider Transaction Report
Form 4/AAmended
Lanza Robert
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2014-09-12+112,000→ 112,000 totalExercise: $8.49Exp: 2024-09-11→ Common Stock (112,000 underlying)
Footnotes (1)
- [F1]Options vest in 24 equal monthly installments on the monthly anniversary of the date of grant subject to continued employment with the Corporation.